Bioventus Inc (BVS)
11.51
+0.10
(+0.88%)
USD |
NASDAQ |
Nov 21, 16:00
11.52
+0.01
(+0.09%)
After-Hours: 20:00
Bioventus Enterprise Value: 1.131B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.131B |
| November 20, 2024 | 1.124B |
| November 19, 2024 | 1.136B |
| November 18, 2024 | 1.114B |
| November 15, 2024 | 1.113B |
| November 14, 2024 | 1.106B |
| November 13, 2024 | 1.108B |
| November 12, 2024 | 1.153B |
| November 11, 2024 | 1.192B |
| November 08, 2024 | 1.151B |
| November 07, 2024 | 1.113B |
| November 06, 2024 | 1.116B |
| November 05, 2024 | 1.129B |
| November 04, 2024 | 1.275B |
| November 01, 2024 | 1.266B |
| October 31, 2024 | 1.266B |
| October 30, 2024 | 1.266B |
| October 29, 2024 | 1.249B |
| October 28, 2024 | 1.229B |
| October 25, 2024 | 1.238B |
| October 24, 2024 | 1.247B |
| October 23, 2024 | 1.243B |
| October 22, 2024 | 1.223B |
| October 21, 2024 | 1.208B |
| October 18, 2024 | 1.221B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.195B |
| October 16, 2024 | 1.219B |
| October 15, 2024 | 1.207B |
| October 14, 2024 | 1.197B |
| October 11, 2024 | 1.168B |
| October 10, 2024 | 1.111B |
| October 09, 2024 | 1.125B |
| October 08, 2024 | 1.133B |
| October 07, 2024 | 1.107B |
| October 04, 2024 | 1.143B |
| October 03, 2024 | 1.138B |
| October 02, 2024 | 1.145B |
| October 01, 2024 | 1.146B |
| September 30, 2024 | 1.156B |
| September 27, 2024 | 1.148B |
| September 26, 2024 | 1.110B |
| September 25, 2024 | 1.147B |
| September 24, 2024 | 1.135B |
| September 23, 2024 | 1.130B |
| September 20, 2024 | 1.162B |
| September 19, 2024 | 1.145B |
| September 18, 2024 | 1.151B |
| September 17, 2024 | 1.131B |
| September 16, 2024 | 1.110B |
| September 13, 2024 | 1.118B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
508.22M
Minimum
May 04 2023
1.299B
Maximum
Jan 11 2022
810.31M
Average
754.78M
Median
Aug 26 2021
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| Insulet Corp | 18.87B |
| Perspective Therapeutics Inc | -63.40M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.824M |
| Revenue (Quarterly) | 138.96M |
| Total Expenses (Quarterly) | 132.38M |
| EPS Diluted (Quarterly) | -0.07 |
| Gross Profit Margin (Quarterly) | 67.32% |
| Profit Margin (Quarterly) | -3.47% |
| Earnings Yield | -5.21% |
| Operating Earnings Yield | 2.39% |
| Normalized Earnings Yield | -1.186 |